CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Vercise DBS settingsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01896115
NCT01896115N/ACompleted
CompareCT.gov

Current Steering to Optimize Deep Brain Stimulation

Boston Scientific Corporation·interventional·Posted Jul 11, 2013·Updated Nov 19, 2020

In Brief

A clinical study evaluating Vercise DBS settings for Parkinson's Disease. Completed, enrolled 40 participants across 10 sites in 5 countries.

Detailed Summary

The objective of the study is to compare different deep brain stimulation (DBS) settings using the commercially approved Boston Scientific Neuromodulation Vercise system.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson's Disease
CountriesAustria, Germany, Italy, United Kingdom, United States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 11, 2013
Enrollment StartJun 1, 2013
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 13.0 years ago

Interventions

Vercise DBS settingsdevice

Deep brain stimulation set at short pulse width and monopolar stimulation using current steering